当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Kerry Brown
Smoking is considered the leading cause of preventable death and chronic disease worldwide. Despite significant funding towards understanding the neurobiology of addiction and options for smoking cessation treatment, tobacco kills more than 8 million people each year.1 Extensive research and neuroimaging studies have helped identify the pathway and mechanisms of dependency, craving, and withdrawal, which allows for targeted treatment options. Current guidelines recommend a combination of pharmacological treatment with behavioral counseling for optimal success.2 However, research continues for innovative interventions. One option being pioneered for addiction treatment is use of transcranial magnetic stimulation (TMS) therapy. When targeting appropriate brain structures, TMS has been shown to neuromodulate the brain pathway associated with addiction. This review of recent literature and studies assesses the ability of TMS to reduce cravings, cigarette consumption, and abstinence.